Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action

作者
Matthew Taylor,Nick Freemantle,John Geddes,Zubin Bhagwagar
出处
期刊:Archives of General Psychiatry [American Medical Association]
卷期号:63 (11): 1217-1217 被引量:407
标识
DOI:10.1001/archpsyc.63.11.1217
摘要

CONTEXT: Selective serotonin reuptake inhibitors (SSRIs) are often described as having a delayed onset of effect in the treatment of depression. However, some trials have reported clinical improvement as early as the first week of treatment. OBJECTIVE: To test the alternative hypotheses of delayed vs early onset of antidepressant action with SSRIs in patients with unipolar depression. DATA SOURCES: Trials identified by searching CENTRAL, The Cochrane Collaboration database of controlled trials (2005), and the reference lists of identified trials and other systematic reviews. STUDY SELECTION: Randomized controlled trials of SSRIs vs placebo for the treatment of unipolar depression in adults that reported outcomes for at least 2 time points in the first 4 weeks of treatment (50 trials from >500 citations identified). Trials were excluded if limited to participants older than 65 years or specific comorbidities. DATA EXTRACTION: Data were extracted on trial design, participant characteristics, and outcomes by a single reviewer. DATA SYNTHESIS: Pooled estimates of treatment effect on depressive symptom rating scales were calculated for weeks 1 through 6 of treatment. In the primary analysis, the pattern of response seen was tested against alternative models of onset of response. The primary analysis incorporated data from 28 randomized controlled trials (n=5872). A model of early treatment response best fit the experimental data. Treatment with SSRIs rather than placebo was associated with clinical improvement by the end of the first week of use. A secondary analysis indicated an increased chance of achieving a 50% reduction in Hamilton Depression Rating Scale scores by 1 week (relative risk, 1.64; 95% confidence interval, 1.2-2.25) with SSRI treatment compared with placebo. CONCLUSIONS: Treatment with SSRIs is associated with symptomatic improvement in depression by the end of the first week of use, and the improvement continues at a decreasing rate for at least 6 weeks.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Yallabo完成签到,获得积分10
刚刚
2秒前
好文章快快来完成签到,获得积分10
2秒前
感动水杯完成签到,获得积分10
2秒前
2秒前
英俊的铭应助生动的访琴采纳,获得10
3秒前
3秒前
科研通AI6.2应助董良嘉采纳,获得10
4秒前
SciGPT应助魏晨采纳,获得10
4秒前
JanaL完成签到,获得积分10
4秒前
在水一方应助朏祀采纳,获得10
5秒前
吴彦祖发布了新的文献求助10
5秒前
5秒前
5秒前
小二郎应助风中的宛白采纳,获得10
6秒前
6秒前
爆米花应助风中的宛白采纳,获得10
6秒前
翔君发布了新的文献求助10
6秒前
7秒前
帅气大象完成签到,获得积分10
8秒前
cauchyhh完成签到 ,获得积分10
9秒前
沧海一声笑完成签到,获得积分10
10秒前
FashionBoy应助郑匕采纳,获得10
10秒前
10秒前
jiang1111发布了新的文献求助10
10秒前
单词发布了新的文献求助10
10秒前
正直画笔发布了新的文献求助10
11秒前
凉宫八月发布了新的文献求助10
12秒前
momo妈咪完成签到,获得积分10
12秒前
13秒前
14秒前
orixero应助科研通管家采纳,获得10
14秒前
科目三应助科研通管家采纳,获得10
14秒前
爆米花应助科研通管家采纳,获得10
14秒前
英姑应助科研通管家采纳,获得10
15秒前
wwww应助科研通管家采纳,获得10
15秒前
15秒前
cdercder应助科研通管家采纳,获得10
15秒前
传奇3应助科研通管家采纳,获得10
15秒前
英俊的铭应助科研通管家采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Effects of Two Weeks of Red Light Therapy on Choroidal Thickness and Axial Length in Young Adults 700
Positive Art Therapy Theory and Practice 600
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Key mechanistic insights into the intramolecular C-H bond amination and double bond aziridination in sulfamate esters catalyzed by dirhodium tetracarboxylate complexes 500
The Neuroscience of Language 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7671792
求助须知:如何正确求助?哪些是违规求助? 9238972
关于积分的说明 19898207
捐赠科研通 7241354
什么是DOI,文献DOI怎么找? 3285164
关于科研通互助平台的介绍 2443387
邀请新用户注册赠送积分活动 2287327